Ohio-localized — This article has been adapted for Ohio patients, referencing state-specific requirements, health department guidance, and local resources including care available at Daystar Urgent Care in Forest Park.

GLP-1 receptor agonists have transformed medical weight loss over the past several years. Once reserved for type 2 diabetes management, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are now FDA-approved for chronic weight management — with clinical trial results showing 15–22% body weight reduction, numbers previously seen only with bariatric surgery.

How GLP-1 medications work

These medications mimic a hormone your gut releases after eating. They slow stomach emptying, reduce appetite signals in the brain, and improve insulin sensitivity. The result: most patients find they're genuinely less hungry, not just disciplined through willpower. This is biochemistry, not a personality change.

Who qualifies?

FDA approval for weight management requires a BMI of 30 or higher, or BMI 27+ with at least one weight-related condition (type 2 diabetes, high blood pressure, or high cholesterol). A medical evaluation determines whether you're an appropriate candidate — not all patients are, and these medications have contraindications.

What a proper supervised program looks like

Reputable programs include:

  • Baseline labs (metabolic panel, A1C, lipids, thyroid)
  • Blood pressure and weight monitoring
  • Gradual dose titration to minimize side effects
  • Regular provider check-ins — at least monthly initially
  • Nutrition and behavioral guidance alongside medication
  • Clear plan for if/when to stop

Avoid programs that mail medication without a real consultation or that never require follow-up bloodwork — these cut corners that matter for safety.

Common side effects

Nausea, constipation, and reduced appetite are common early on and typically improve with dose titration. Rare but serious: pancreatitis, gallbladder issues. Anyone with a personal or family history of medullary thyroid cancer or MEN2 should not use these medications.

Medical weight loss at Daystar

We offer supervised medical weight loss consultations in Forest Park and by telehealth across Ohio. Initial consultation is $99, includes intake evaluation and baseline labs ordered. Not everyone will qualify for GLP-1 medications, but we'll give you an honest assessment of what options fit your situation.

Source: FDA — https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-approved-weight-management
This article summarizes public health information. Always consult a licensed provider for personal medical decisions.

Frequently asked questions

Yes, with a proper evaluation. We schedule a weight loss consultation, review your health history and baseline labs, and determine whether you're an appropriate candidate. GLP-1 medications require ongoing monitoring — we build that into the program.

Coverage for GLP-1 medications varies widely by plan. Some plans cover Wegovy and Zepbound; many do not. Our consultation is $99 self-pay regardless. We'll help you navigate the medication cost landscape during your visit.